Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bionix is a medical device company that specializes in developing innovative, non-invasive solutions for healthcare professionals. Founded in 1984 by a pediatrician and a nuclear engineer, the company focuses on several key areas including ear care, pain management, and neonatal health. Their product portfolio includes well-known items such as the ShotBlocker for reducing injection pain and various ear irrigation and suction systems. Bionix aims to improve patient comfort and clinical outcomes through simple yet effective engineering. The company is headquartered in Toledo, Ohio, and serves a global market. In 2022, Bionix was acquired by the private equity firm LongueVue Capital to accelerate its growth and product development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bionix.